Tango Therapeutics, Inc. (TNGX) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$111.29M | +23.6% |
| 2024 | -$145.59M | -27.5% |
| 2023 | -$114.17M | -2.8% |
| 2022 | -$111.07M | -90.9% |
| 2021 | -$58.19M | -11.5% |
| 2020 | -$52.20M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$111.29M | +23.6% |
| 2024 | -$145.59M | -27.5% |
| 2023 | -$114.17M | -2.8% |
| 2022 | -$111.07M | -90.9% |
| 2021 | -$58.19M | -11.5% |
| 2020 | -$52.20M | — |